Abstract: The present disclosure relates to a functional composition for the prevention, amelioration or treatment of obesity or lipid-related metabolic disorders, which comprises a steroid sulfatase inhibitor as an active ingredient.

Abstract: A steroid sulfatase inhibitor provided by the present invention is a safe substance without toxicity and adverse effects, has inhibitory activity against various viruses, and thus is capable of effectively preventing, ameliorating, or treating viral infections or diseases caused by viral infections.

Abstract: The present disclosure relates to a functional composition for the prevention, amelioration or treatment of obesity or lipid-related metabolic disorders, which comprises a steroid sulfatase inhibitor as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a bone-related disease; and the pharmaceutical composition is very effective in preventing or treating bone-related diseases in that it not only promotes differentiation of preosteoblast cells into osteoblasts to induce production of mineralized nodules, but also, at the same time, inhibits differentiation of bone marrow cells into osteoclasts and the function of osteoclasts so that bone homeostasis is effectively regulated.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a bone-related disease; and the pharmaceutical composition is very effective in preventing or treating bone-related diseases in that it not only promotes differentiation of preosteoblast cells into osteoblasts to induce production of mineralized nodules, but also, at the same time, inhibits differentiation of bone marrow cells into osteoclasts and the function of osteoclasts so that bone homeostasis is effectively regulated.

Abstract: The present disclosure relates to a functional composition for the prevention, amelioration or treatment of obesity or lipid-related metabolic disorders, which comprises a steroid sulfatase inhibitor as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a bone-related disease; and the pharmaceutical composition is very effective in preventing or treating bone-related diseases in that it not only promotes differentiation of preosteoblast cells into osteoblasts to induce production of mineralized nodules, but also, at the same time, inhibits differentiation of bone marrow cells into osteoclasts and the function of osteoclasts so that bone homeostasis is effectively regulated.

Abstract: The present invention provides a vibration absorbing device. A vibration absorbing device according to an exemplary embodiment of the present invention includes a first magnetic force generation member fixed to an external portion that is separated from a vibration source and a second magnetic force generation member provided in one side of the vibration source. When vibration is generated by the vibration source, the direction and magnitude of a magnetic force of one of the first magnetic force generation member and the second magnetic force generation can be controlled such that the second magnetic force generation member can move in a direction for attenuating the vibration of the vibration source.

Abstract: The present invention provides a vibration absorbing device. A vibration absorbing device according to an exemplary embodiment of the present invention includes a first magnetic force generation member fixed to an external portion that is separated from a vibration source and a second magnetic force generation member provided in one side of the vibration source. When vibration is generated by the vibration source, the direction and magnitude of a magnetic force of one of the first magnetic force generation member and the second magnetic force generation can be controlled such that the second magnetic force generation member can move in a direction for attenuating the vibration of the vibration source.